Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Covalon Technologies Ltd (CVALF)

Covalon Technologies Ltd (CVALF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth Business Wire - Thu Dec 11, 2025

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 fourth quarter and full 2025 fiscal year results...

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results Business Wire - Thu Dec 4, 2025

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2025 financial results on Thursday, December...

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)
Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength Business Wire - Wed Nov 19, 2025

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the payment on November 18, 2025 of its first ever dividend...

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)
Covalon Declares First Ever Special Cash Dividend Business Wire - Tue Oct 21, 2025

Covalon Technologies Ltd. (the “ Company” or “ Covalon” ) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Directors...

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)
Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025 Business Wire - Mon Oct 20, 2025

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company improving lives through innovative wound care, vascular access, and surgical solutions,...

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)
Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference Business Wire - Tue Oct 7, 2025

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety and clinical outcomes, today announced...

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON Business Wire - Thu Sep 25, 2025

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation in the Association of Pediatric Hematology/Oncology...

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)
Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair Business Wire - Tue Sep 23, 2025

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. Abe Schwartz has been elected Chair of the Board of...

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)
Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting Business Wire - Thu Sep 18, 2025

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation at the Association for Vascular Access (AVA) Annual...

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)
Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs) Business Wire - Tue Sep 16, 2025

Peer-reviewed study reports a 78% reduction in hospital-wide CLABSI rates from 2023 to 2024

CVALF : 1.2300 (+0.82%)
COV.VN : 1.590 (-1.24%)

Barchart Exclusives

Should You Buy AT&T Stock After Its Amazon Leo Win? Barchart - 47 minutes ago
AT&T’s Amazon Leo deal is strengthening its connectivity strategy and lifting analyst sentiment. Could the alliance drive T stock higher? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot